Cell-by-Cell. Gene-by-Gene. Cancer-Fighting Therapies Built Around You.
Sat Prabhava delivers next-generation ATMPs—personalised cellular, viral, and gene-directed therapies that activate your immune system and correct cancer-related dysfunction at the source. These are advanced, immune-integrated strategies that go beyond conventional treatment for long-term, precision-based cancer control.
- Cellular Therapies
Cellular therapies are a form of autologous cancer immunotherapy, where we isolate specific immune cells from your body, activate or modify them in a laboratory, and reinfuse them to target and kill cancer more effectively. These therapies work on the principle that cancer evades or suppresses immune surveillance, and by enhancing your immune cells’ strength and accuracy, we restore the body’s natural ability to fight disease. - Natural Killer (NK) Cell Therapy
Natural Killer cells are part of your innate immune system, capable of destroying abnormal cells without prior sensitisation. Cancer cells often reduce MHC expression to avoid T-cell detection—but NK cells are uniquely equipped to target such cells. - Dendritic Cell Therapy (DC Vaccines)
Dendritic cells are antigen-presenting cells that act as messengers between the innate and adaptive immune systems. In DC therapy, dendritic cells are harvested and “trained” with tumour antigens in vitro, then reinjected to instruct T cells to attack tumour cells. - Cytokine-Induced Killer (CIK) Cells
CIK cells combine the properties of T cells and NK cells, offering non-MHC-restricted cytotoxicity and enhanced tumour recognition. These are expanded from peripheral blood mononuclear cells using cytokines like IFN-γ, IL-2, and anti-CD3. - Tumour-Infiltrating Lymphocytes (TIL) Therapy
TIL therapy involves isolating immune cells that have already penetrated the tumour, expanding them in the lab, and reinfusing them in large numbers to help them overwhelm the cancer. - Gene Silencing Therapies
We use precision gene-silencing strategies (e.g., siRNA, miRNA) to selectively shut down oncogenes , blocking the pathways cancer cells depend on. Molecular profiling to detects overexpressed genes and identify therapeutic targets throughtranscriptomics and mutation analysis. By directly silencing tumour-promoting genes, stop cancer from spreading. - Oncolytic Virus Therapies
Oncolytic viruses are modified viruses that infect and destroy only cancer cells, triggering an immune response in the tumour microenvironment. - Personalised Cancer Vaccines
Sat Prabhava offers neoantigen and peptide-based cancer vaccines made from your own tumour’s to generate a targeted immune response.
How We Personalise It:
At Sat Prabhava, ATMPs are tailored using your tumour’s genomic profile, immune markers, and chemosensitivity results. This helps us match the right therapy—such as NK cells, DC vaccines, gene silencing, or oncolytic viruses—to your cancer’s specific weaknesses, adjusting as your response evolves.
Why It Matters to You:
Personalised ATMPs go beyond standard care, offering targeted, low-toxicity options that work even when other treatments fail. Built around your body’s unique biology, they improve outcomes, reduce relapse risk, and offer longer-lasting cancer control.
At Sat Prabhava, we use tomorrow’s medicine today—designed around your body’s biology to give you deeper, more durable cancer control.”